Skip to main content
Erschienen in: Pediatric Radiology 2/2024

25.01.2024 | Original Article

Left ventricular concentric hypertrophy with cardiac magnetic resonance imaging improves risk stratification in patients with Duchenne muscular dystrophy: a prospective cohort study

verfasst von: Wei-feng Yuan, Li Yu, Ke Xu, Rong Xu, Hang Fu, Yu Song, Zi-qi Zhou, Ting Xu, Xiao-tang Cai, Ying-kun Guo, Hua-yan Xu

Erschienen in: Pediatric Radiology | Ausgabe 2/2024

Einloggen, um Zugang zu erhalten

Abstract

Background

The development of left ventricular (LV) remodeling has been associated with an increased cardiovascular risk and cardiogenic death, and different patterns of remodeling result in varying levels of prognosis.

Objective

To investigate the association between different patterns of LV remodeling and clinical outcomes in the preclinical stage of patients with Duchenne muscular dystrophy (DMD).

Materials and methods

A total of 148 patients with DMD and 43 sex- and age-matched healthy participants were enrolled. We used the four-quadrant analysis method to investigate LV remodeling based on cardiac magnetic resonance (MR) imaging. Kaplan-Meier curves were generated to illustrate the event-free survival probability stratified by the LV remodeling pattern. Cox regression models were constructed and compared to evaluate the incremental predictive value of the LV remodeling pattern.

Results

During the median follow-up period of 2.2 years, all-cause death, cardiomyopathy, and ventricular arrhythmia occurred in 5, 35, and 7 patients, respectively. LV concentric hypertrophy (hazard ratio 2.91, 95% confidence interval 1.47–5.75, P=0.002) was an independent predictor of composite endpoint events. Compared to the model without LV concentric hypertrophy, the model with LV concentric hypertrophy had significant incremental predictive value (chi-square value 33.5 vs. 25.2, P=0.004).

Conclusion

Age and late gadolinium enhancement positivity were positively correlated with clinical outcomes according to the prediction models. LV concentric hypertrophy was also an independent predictor for risk stratification and provided incremental value for predicting clinical outcomes in the preclinical stage of patients with DMD.

Graphical Abstract

Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Landfeldt E, Thompson R, Sejersen T et al (2020) Life expectancy at birth in Duchenne muscular dystrophy: a systematic review and meta-analysis. Eur J Epidemiol 35:643–653CrossRefPubMedPubMedCentral Landfeldt E, Thompson R, Sejersen T et al (2020) Life expectancy at birth in Duchenne muscular dystrophy: a systematic review and meta-analysis. Eur J Epidemiol 35:643–653CrossRefPubMedPubMedCentral
2.
Zurück zum Zitat Broomfield J, Hill M, Guglieri M et al (2021) Life expectancy in Duchenne muscular dystrophy: reproduced individual patient data meta-analysis. Neurology 97:e2304–e2314CrossRefPubMedPubMedCentral Broomfield J, Hill M, Guglieri M et al (2021) Life expectancy in Duchenne muscular dystrophy: reproduced individual patient data meta-analysis. Neurology 97:e2304–e2314CrossRefPubMedPubMedCentral
3.
Zurück zum Zitat D’Amario D, Amodeo A, Adorisio R et al (2017) A current approach to heart failure in Duchenne muscular dystrophy. Heart 103:1770–1779CrossRefPubMed D’Amario D, Amodeo A, Adorisio R et al (2017) A current approach to heart failure in Duchenne muscular dystrophy. Heart 103:1770–1779CrossRefPubMed
4.
Zurück zum Zitat Jefferies JL, Eidem BW, Belmont JW et al (2005) Genetic predictors and remodeling of dilated cardiomyopathy in muscular dystrophy. Circulation 112:2799–2804CrossRefPubMed Jefferies JL, Eidem BW, Belmont JW et al (2005) Genetic predictors and remodeling of dilated cardiomyopathy in muscular dystrophy. Circulation 112:2799–2804CrossRefPubMed
5.
Zurück zum Zitat Lieb W, Gona P, Larson MG et al (2014) The natural history of left ventricular geometry in the community: clinical correlates and prognostic significance of change in LV geometric pattern. JACC Cardiovasc Imaging 7:870–878CrossRefPubMedPubMedCentral Lieb W, Gona P, Larson MG et al (2014) The natural history of left ventricular geometry in the community: clinical correlates and prognostic significance of change in LV geometric pattern. JACC Cardiovasc Imaging 7:870–878CrossRefPubMedPubMedCentral
6.
Zurück zum Zitat Lu C, Chen J, Suksaranjit P et al (2020) Regional myocardial remodeling characteristics correlates with cardiac events in sarcoidosis. J Magn Reson Imaging 52:499–509CrossRefPubMed Lu C, Chen J, Suksaranjit P et al (2020) Regional myocardial remodeling characteristics correlates with cardiac events in sarcoidosis. J Magn Reson Imaging 52:499–509CrossRefPubMed
7.
Zurück zum Zitat Rodriguez-Palomares JF, Gavara J, Ferreira-González I et al (2019) Prognostic value of initial left ventricular remodeling in patients with reperfused STEMI. Jacc-cardiovasc Imag 12:2445–2456CrossRef Rodriguez-Palomares JF, Gavara J, Ferreira-González I et al (2019) Prognostic value of initial left ventricular remodeling in patients with reperfused STEMI. Jacc-cardiovasc Imag 12:2445–2456CrossRef
8.
Zurück zum Zitat Krumholz HM, Larson M, Levy D (1995) Prognosis of left ventricular geometric patterns in the Framingham heart study. J Am Coll Cardiol 25:879–884CrossRefPubMed Krumholz HM, Larson M, Levy D (1995) Prognosis of left ventricular geometric patterns in the Framingham heart study. J Am Coll Cardiol 25:879–884CrossRefPubMed
9.
Zurück zum Zitat Greally E, Davison BJ, Blain A et al (2013) Heterogeneous abnormalities of in-vivo left ventricular calcium influx and function in mouse models of muscular dystrophy cardiomyopathy. J Cardiovasc Magn Reson 15:4CrossRefPubMedPubMedCentral Greally E, Davison BJ, Blain A et al (2013) Heterogeneous abnormalities of in-vivo left ventricular calcium influx and function in mouse models of muscular dystrophy cardiomyopathy. J Cardiovasc Magn Reson 15:4CrossRefPubMedPubMedCentral
10.
Zurück zum Zitat Jing L, Binkley CM, Suever JD et al (2016) Cardiac remodeling and dysfunction in childhood obesity: a cardiovascular magnetic resonance study. J Cardiovasc Magn Reson 18:28CrossRefPubMedPubMedCentral Jing L, Binkley CM, Suever JD et al (2016) Cardiac remodeling and dysfunction in childhood obesity: a cardiovascular magnetic resonance study. J Cardiovasc Magn Reson 18:28CrossRefPubMedPubMedCentral
11.
Zurück zum Zitat Ganau A, Devereux RB, Roman MJ et al (1992) Patterns of left ventricular hypertrophy and geometric remodeling in essential hypertension. J Am Coll Cardiol 19:1550–1558CrossRefPubMed Ganau A, Devereux RB, Roman MJ et al (1992) Patterns of left ventricular hypertrophy and geometric remodeling in essential hypertension. J Am Coll Cardiol 19:1550–1558CrossRefPubMed
12.
Zurück zum Zitat Ng ACT, Delgado V, Borlaug BA, Bax JJ (2021) Diabesity: The combined burden of obesity and diabetes on heart disease and the role of imaging. Nat Rev Cardiol 18:291–304CrossRefPubMed Ng ACT, Delgado V, Borlaug BA, Bax JJ (2021) Diabesity: The combined burden of obesity and diabetes on heart disease and the role of imaging. Nat Rev Cardiol 18:291–304CrossRefPubMed
13.
Zurück zum Zitat Pezel T, Viallon M, Croisille P et al (2021) Imaging interstitial fibrosis, left ventricular remodeling, and function in stage A and B heart failure. JACC Cardiovasc Imaging 14:1038–1052CrossRefPubMed Pezel T, Viallon M, Croisille P et al (2021) Imaging interstitial fibrosis, left ventricular remodeling, and function in stage A and B heart failure. JACC Cardiovasc Imaging 14:1038–1052CrossRefPubMed
14.
Zurück zum Zitat Rudolph A, Abdel-Aty H, Bohl S et al (2009) Noninvasive detection of fibrosis applying contrast-enhanced cardiac magnetic resonance in different forms of left ventricular hypertrophy relation to remodeling. J Am Coll Cardiol 53:284–291CrossRefPubMed Rudolph A, Abdel-Aty H, Bohl S et al (2009) Noninvasive detection of fibrosis applying contrast-enhanced cardiac magnetic resonance in different forms of left ventricular hypertrophy relation to remodeling. J Am Coll Cardiol 53:284–291CrossRefPubMed
15.
Zurück zum Zitat Jing L, Nevius CD, Friday CM et al (2017) Ambulatory systolic blood pressure and obesity are independently associated with left ventricular hypertrophic remodeling in children. J Cardiovasc Magn Reson 19:86CrossRefPubMedPubMedCentral Jing L, Nevius CD, Friday CM et al (2017) Ambulatory systolic blood pressure and obesity are independently associated with left ventricular hypertrophic remodeling in children. J Cardiovasc Magn Reson 19:86CrossRefPubMedPubMedCentral
16.
Zurück zum Zitat Bushby K, Finkel R, Birnkrant DJ et al (2010) Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management. Lancet Neurol 9:77–93 Bushby K, Finkel R, Birnkrant DJ et al (2010) Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management. Lancet Neurol 9:77–93
17.
Zurück zum Zitat Birnkrant DJ, Bushby K, Bann CM et al (2018) Diagnosis and management of Duchenne muscular dystrophy, part 2: respiratory, cardiac, bone health, and orthopaedic management. Lancet Neurol 17:347–361 Birnkrant DJ, Bushby K, Bann CM et al (2018) Diagnosis and management of Duchenne muscular dystrophy, part 2: respiratory, cardiac, bone health, and orthopaedic management. Lancet Neurol 17:347–361
18.
Zurück zum Zitat Feingold B, Mahle WT, Auerbach S et al (2017) Management of cardiac involvement associated with neuromuscular diseases: a scientific statement from the American Heart Association. Circulation 136:e200–e231 Feingold B, Mahle WT, Auerbach S et al (2017) Management of cardiac involvement associated with neuromuscular diseases: a scientific statement from the American Heart Association. Circulation 136:e200–e231
19.
Zurück zum Zitat Siddiqui S, Alsaied T, Henson SE et al (2020) Left ventricular magnetic resonance imaging strain predicts the onset of Duchenne muscular dystrophy-associated cardiomyopathy. Circ Cardiovasc Imaging 13:e011526CrossRefPubMed Siddiqui S, Alsaied T, Henson SE et al (2020) Left ventricular magnetic resonance imaging strain predicts the onset of Duchenne muscular dystrophy-associated cardiomyopathy. Circ Cardiovasc Imaging 13:e011526CrossRefPubMed
20.
Zurück zum Zitat de Simone G, Daniels SR, Devereux RB et al (1992) Left ventricular mass and body size in normotensive children and adults: assessment of allometric relations and impact of overweight. J Am Coll Cardiol 20:1251–1260CrossRefPubMed de Simone G, Daniels SR, Devereux RB et al (1992) Left ventricular mass and body size in normotensive children and adults: assessment of allometric relations and impact of overweight. J Am Coll Cardiol 20:1251–1260CrossRefPubMed
21.
Zurück zum Zitat Xu L, Keenan BT, Maislin D et al (2021) Effect of obstructive sleep apnea and positive airway pressure therapy on cardiac remodeling as assessed by cardiac biomarker and magnetic resonance imaging in nonobese and obese adults. Hypertension 77:980–992CrossRefPubMed Xu L, Keenan BT, Maislin D et al (2021) Effect of obstructive sleep apnea and positive airway pressure therapy on cardiac remodeling as assessed by cardiac biomarker and magnetic resonance imaging in nonobese and obese adults. Hypertension 77:980–992CrossRefPubMed
22.
Zurück zum Zitat Amier RP, Marcks N, Hooghiemstra AM et al (2021) Hypertensive exposure markers by MRI in relation to cerebral small vessel disease and cognitive impairment. JACC Cardiovasc Imaging 14:176–185CrossRefPubMed Amier RP, Marcks N, Hooghiemstra AM et al (2021) Hypertensive exposure markers by MRI in relation to cerebral small vessel disease and cognitive impairment. JACC Cardiovasc Imaging 14:176–185CrossRefPubMed
23.
Zurück zum Zitat Vickers AJ, Cronin AM, Begg CB (2011) One statistical test is sufficient for assessing new predictive markers. BMC Med Res Methodol 11:1–7CrossRef Vickers AJ, Cronin AM, Begg CB (2011) One statistical test is sufficient for assessing new predictive markers. BMC Med Res Methodol 11:1–7CrossRef
24.
Zurück zum Zitat Cha JJ, Kim IS, Kim JY et al (2022) The association between cardiac involvement and long-term clinical outcomes in patients with Duchenne muscular dystrophy. ESC Heart Fail 9:2199–2206CrossRefPubMedPubMedCentral Cha JJ, Kim IS, Kim JY et al (2022) The association between cardiac involvement and long-term clinical outcomes in patients with Duchenne muscular dystrophy. ESC Heart Fail 9:2199–2206CrossRefPubMedPubMedCentral
25.
Zurück zum Zitat D’Amario D, Gowran A, Canonico F et al (2018) Dystrophin cardiomyopathies: clinical management, molecular pathogenesis and evolution towards precision medicine. J Clin Med 7:291CrossRefPubMedPubMedCentral D’Amario D, Gowran A, Canonico F et al (2018) Dystrophin cardiomyopathies: clinical management, molecular pathogenesis and evolution towards precision medicine. J Clin Med 7:291CrossRefPubMedPubMedCentral
26.
Zurück zum Zitat Birnkrant DJ, Bushby K, Bann CM et al (2018) Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and neuromuscular, rehabilitation, endocrine, and gastrointestinal and nutritional management. Lancet Neurol 17:251–267CrossRefPubMedPubMedCentral Birnkrant DJ, Bushby K, Bann CM et al (2018) Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and neuromuscular, rehabilitation, endocrine, and gastrointestinal and nutritional management. Lancet Neurol 17:251–267CrossRefPubMedPubMedCentral
27.
Zurück zum Zitat Henson SE, Lang SM, Khoury PR et al (2021) The effect of adiposity on cardiovascular function and myocardial fibrosis in patients with Duchenne muscular dystrophy. J Am Heart Assoc 10:e021037CrossRefPubMedPubMedCentral Henson SE, Lang SM, Khoury PR et al (2021) The effect of adiposity on cardiovascular function and myocardial fibrosis in patients with Duchenne muscular dystrophy. J Am Heart Assoc 10:e021037CrossRefPubMedPubMedCentral
28.
Zurück zum Zitat Menon SC, Etheridge SP, Liesemer KN et al (2014) Predictive value of myocardial delayed enhancement in Duchenne muscular dystrophy. Pediatric Cardiol 35:1279–1285CrossRef Menon SC, Etheridge SP, Liesemer KN et al (2014) Predictive value of myocardial delayed enhancement in Duchenne muscular dystrophy. Pediatric Cardiol 35:1279–1285CrossRef
30.
Zurück zum Zitat Moons KG, de Groot JA, Linnet K et al (2012) Quantifying the added value of a diagnostic test or marker. Clin Chem 58:1408–1417CrossRefPubMed Moons KG, de Groot JA, Linnet K et al (2012) Quantifying the added value of a diagnostic test or marker. Clin Chem 58:1408–1417CrossRefPubMed
Metadaten
Titel
Left ventricular concentric hypertrophy with cardiac magnetic resonance imaging improves risk stratification in patients with Duchenne muscular dystrophy: a prospective cohort study
verfasst von
Wei-feng Yuan
Li Yu
Ke Xu
Rong Xu
Hang Fu
Yu Song
Zi-qi Zhou
Ting Xu
Xiao-tang Cai
Ying-kun Guo
Hua-yan Xu
Publikationsdatum
25.01.2024
Verlag
Springer Berlin Heidelberg
Erschienen in
Pediatric Radiology / Ausgabe 2/2024
Print ISSN: 0301-0449
Elektronische ISSN: 1432-1998
DOI
https://doi.org/10.1007/s00247-024-05856-1

Weitere Artikel der Ausgabe 2/2024

Pediatric Radiology 2/2024 Zur Ausgabe

Mammakarzinom: Brustdichte beeinflusst rezidivfreies Überleben

26.05.2024 Mammakarzinom Nachrichten

Frauen, die zum Zeitpunkt der Brustkrebsdiagnose eine hohe mammografische Brustdichte aufweisen, haben ein erhöhtes Risiko für ein baldiges Rezidiv, legen neue Daten nahe.

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

Klinikreform soll zehntausende Menschenleben retten

15.05.2024 Klinik aktuell Nachrichten

Gesundheitsminister Lauterbach hat die vom Bundeskabinett beschlossene Klinikreform verteidigt. Kritik an den Plänen kommt vom Marburger Bund. Und in den Ländern wird über den Gang zum Vermittlungsausschuss spekuliert.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.